Compare QGEN & UMBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QGEN | UMBF |
|---|---|---|
| Founded | 1986 | 1913 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 8.9B |
| IPO Year | 1996 | N/A |
| Metric | QGEN | UMBF |
|---|---|---|
| Price | $45.08 | $115.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 11 |
| Target Price | $50.07 | ★ $136.27 |
| AVG Volume (30 Days) | ★ 1.1M | 517.3K |
| Earning Date | 02-04-2026 | 01-27-2026 |
| Dividend Yield | ★ 3.36% | 1.50% |
| EPS Growth | ★ 331.20 | 10.98 |
| EPS | 1.84 | ★ 8.89 |
| Revenue | $2,070,781,000.00 | ★ $2,217,071,000.00 |
| Revenue This Year | $7.07 | $69.52 |
| Revenue Next Year | $6.14 | $7.83 |
| P/E Ratio | $24.46 | ★ $12.94 |
| Revenue Growth | 5.32 | ★ 45.52 |
| 52 Week Low | $37.63 | $82.00 |
| 52 Week High | $51.88 | $126.14 |
| Indicator | QGEN | UMBF |
|---|---|---|
| Relative Strength Index (RSI) | 42.69 | 47.62 |
| Support Level | $45.13 | $118.17 |
| Resistance Level | $46.02 | $119.45 |
| Average True Range (ATR) | 0.61 | 1.78 |
| MACD | -0.04 | -0.54 |
| Stochastic Oscillator | 29.34 | 6.49 |
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
UMB Financial Corp, or UMBF, is a financial services holding company offering a suite of banking services and asset servicing to its customers in the United States and around the world. Its client base includes commercial, institutional, and personal customers. Along with its subsidiaries, the company operates in the following business segments: Commercial Banking, Institutional Banking, and Personal Banking. A majority of its revenue is generated from the Commercial Banking segment, which serves the commercial banking and treasury management needs of small to middle-market businesses through various products and services such as commercial loans, commercial real estate financing, commercial credit cards, letters of credit, loan syndication services, consultative services, and others.